Health Catalyst Inc
NASDAQ:HCAT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Health Catalyst Inc
NASDAQ:HCAT
|
US |
|
H
|
Hexagon Composites ASA
SWB:2HX
|
NO |
|
Adobe Inc
NASDAQ:ADBE
|
US |
|
Antipa Minerals Ltd
OTC:ATPMF
|
AU |
|
A
|
Advtech Ltd
JSE:ADH
|
ZA |
|
W
|
WiseTech Global Ltd
OTC:WTCHF
|
AU |
|
C
|
Carmax Inc
BMV:KMX
|
US |
|
N
|
Newmont Corporation
ASX:NEM
|
US |
|
BRP Inc
TSX:DOO
|
CA |
|
Sarepta Therapeutics Inc
NASDAQ:SRPT
|
US |
|
Smartphoto Group NV
XBRU:SMAR
|
BE |
|
I
|
Inchcape PLC
F:IJCA
|
UK |
|
ETSY Inc
NASDAQ:ETSY
|
US |
|
Sichuan Changhong Electric Co Ltd
SSE:600839
|
CN |
|
Banc of California Inc
NYSE:BANC
|
US |
|
Cooper Companies Inc
NASDAQ:COO
|
US |
|
China Coal Energy Co Ltd
SSE:601898
|
CN |
|
Accuray Inc
NASDAQ:ARAY
|
US |
|
M
|
Manulife Financial Corp
XPHS:MFC
|
CA |
|
Hitachi Ltd
F:HIAA
|
JP |
|
D
|
Dentsu Group Inc
XMUN:DEN
|
JP |
|
X Fab Silicon Foundries EV
PAR:XFAB
|
BE |
Wall St Price Targets
HCAT Price Targets Summary
Health Catalyst Inc
According to Wall Street analysts, the average 1-year price target for
HCAT is 1.83 USD with a low forecast of 1.01 USD and a high forecast of 2.1 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is HCAT's stock price target?
Price Target
1.83
USD
According to Wall Street analysts, the average 1-year price target for
HCAT is 1.83 USD with a low forecast of 1.01 USD and a high forecast of 2.1 USD.
What is the Revenue forecast for Health Catalyst Inc?
Projected CAGR
-7%
Over the last 7 years, the compound annual growth rate for Revenue has been 16%. The projected CAGR for the next 3 years is -7%.